2321488-47-3

2321488-47-3 structure

2321488-47-3 structure

Name: Lepzacitinib
Chemical Name: Lepzacitinib
CAS Number: 2321488-47-3
Molecular Formula: C₁₈H₂₁N₅O₃
Molecular Weight: 355.39
Catalog: Signaling Pathways Epigenetics JAK
Create Date: 2023-09-29 17:06:40
Modify Date: 2024-01-12 20:15:27
Lepzacitinib is a Janus kinase inhibitor targeting to JAK 1/3. Lepzacitinib exhibits anti-inflammatory effect and inhibits atopic dermatitis and other skin diseases[1].

Name	Lepzacitinib

Description	Lepzacitinib is a Janus kinase inhibitor targeting to JAK 1/3. Lepzacitinib exhibits anti-inflammatory effect and inhibits atopic dermatitis and other skin diseases[1].
Related Catalog	Signaling Pathways >> JAK/STAT Signaling >> JAK Signaling Pathways >> Epigenetics >> JAK Signaling Pathways >> Stem Cell/Wnt >> JAK Research Areas >> Inflammation/Immunology
Target	JAK 1/3[1]
References	[1]. Anderson, et al. Preparation of substituted pyrrolopyridine compounds as JAK inhibitors. World Intellectual Property Organization, WO2019090158 A1 2019-05-09.

Molecular Formula	C₁₈H₂₁N₅O₃
Molecular Weight	355.39